UPDATE: Morgan Stanley Reiterates On Walgreen Company As Inversion Debate Continues
In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company (NYSE: WAG), but removed the $75.00 price target.
In the report, Morgan Stanley noted, “Political debate intensifying around high profile tax inversion deals adding to the uncertainty around the plausibility of inversion for WAG. While prospects for inversion have been a key debate for WAG shares, we see opportunities for the combined WAG/AB to lower tax rate and expand margins independent of a corporate inversion.”
Walgreen Company closed on Friday at $68.66.
Latest Ratings for WAG
|Dec 2014||JP Morgan||Maintains||Overweight|
|Dec 2014||SunTrust Robinson Humphrey||Downgrades||Buy||Neutral|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.